One Health Pakistan

06/02/2026

🌍 Advancing One Health Solutions to Combat Antimicrobial Resistance (AMR)

Dr. Qadeer Ahsan, Team Lead, DAI Fleming Fund Country Grant Pakistan, participated in the Cefas Antimicrobial Resistance (AMR) One Health Conference held in Bangkok, Thailand (2–4 February 2026).

The conference brought together global experts from human health, animal health, environmental, fisheries, and aquaculture sectors to advance collaborative, cross-sectoral responses to AMR through a One Health approach.

Convened by the UK’s FAO Reference Centre, the event was organized in collaboration with Mott MacDonald, the Food and Drug Administration of Thailand, the Thailand Department of Livestock Development, Chulalongkorn University, Singapore NParks, and the FAO Regional Office for Asia and the Pacific.

As a panelist and speaker, Dr. Ahsan delivered a presentation titled:
“Sustaining One Health AMR Surveillance Beyond Donor Funding: Pakistan’s Transition Journey”, sharing Pakistan’s experiences, lessons learned, and pathways toward nationally owned and sustainable AMR surveillance systems.

This engagement reflects the Fleming Fund Country Grant Pakistan’s continued commitment to strengthening sustainable, integrated One Health AMR surveillance and contributing to global dialogue and learning.

04/02/2026

🎗️ World Cancer Day 2026 – Together, We Fight
On World Cancer Day, we recognize the global impact of cancer and reaffirm our commitment to raising awareness, promoting early detection, and supporting patients and communities.
At Fleming Fund Country Grant Pakistan (FFCGP), our work goes beyond antimicrobial resistance. We understand that infections and drug resistance can complicate cancer treatment and outcomes. Through our advocacy, awareness campaigns, and capacity-building initiatives, we engage healthcare professionals and communities to improve infection prevention, safe treatment practices, and informed healthcare choices—critical components of comprehensive cancer care.
By combining evidence-based interventions with community engagement, FFCGP strives to reduce preventable complications in cancer care, empower healthcare providers, and support healthier, resilient communities.
This World Cancer Day, let’s continue to educate, support, and act—because every informed choice, every preventive step, and every collaborative effort counts.
💡 Share your story, support patients, and highlight initiatives that make a real difference.

26/01/2026

Strengthening sustainable responses to antimicrobial resistance (AMR) requires leadership, collaboration, and long-term commitment.

The Country Roundtable on Sustainability of Antimicrobial Resistance, Use & Consumption (AMR/U/C) Surveillance in Pakistan brought together senior government leadership, technical experts, and development partners to reflect on progress and define the way forward for integrated AMR surveillance systems.

The event was honoured by the participation of Dr. Malik Mukhtar Ahmad Bharath, State Minister for National Health Services, Regulations & Coordination, whose closing remarks reaffirmed the Government of Pakistan’s commitment to sustaining AMR surveillance through policy alignment and multisectoral coordination. The roundtable also featured remarks by Tine Knott, President & CEO of DAI, highlighting the importance of national ownership, data-driven decision-making, and long-term sustainability of AMR initiatives.

Through strategic presentations and panel discussions, stakeholders from human health, animal health, environment, and regulatory sectors engaged in evidence-based dialogue under a One Health framework, reinforcing collective action to safeguard the effectiveness of life-saving medicines.

📌 Swipe through the carousel to explore key moments and insights from the roundtable.

26/01/2026

On World Leprosy Day | 26 January 2026, DAI Fleming Fund Country Grant Pakistan reaffirms its commitment to eliminating leprosy and ensuring timely, equitable access to quality care for all.

Although leprosy is curable, its control in Pakistan continues to face serious challenges—delayed diagnosis, persistent stigma, and the growing threat of antimicrobial resistance (AMR).

Leprosy treatment relies on effective multi-drug therapy. The emergence of resistance, particularly to rifampicin, risks treatment failure, prolonged transmission, and preventable disability. This makes strong AMR surveillance, laboratory capacity strengthening, and rational use of antibiotics critical to sustaining leprosy control efforts.

Through the Fleming Fund, DAI supports Pakistan in building robust AMR surveillance systems, strengthening laboratories, and developing a skilled workforce—contributing to early detection of resistance and protecting life-saving medicines.

On this day, we call for continued collaboration to:
Integrate leprosy within national AMR strategies
Tackle stigma through awareness and inclusion
Safeguard effective treatment so no one is left behind

22/01/2026

📹 In the Spotlight: AMR Sustainability Dialogue Covered by PTV News

We are pleased to share that the recently held Country Roundtable on Sustainability of Antimicrobial Resistance, Use & Consumption (AMR/U/C) Surveillance in Islamabad was featured on PTV News!

This high-level roundtable brought together government leaders, technical experts, and development partners to review progress on antimicrobial resistance (AMR) surveillance in Pakistan and explore sustainable, multisectoral solutions. With the One Health approach at its core, discussions focused on strengthening integrated surveillance systems, translating data into policy, and ensuring long-term resilience of public health interventions.

Watch the coverage here: 👉 https://www.facebook.com/reel/2384275242042637

Hosted in collaboration with the National Institutes of Health (NIH) and the Fleming Fund Country Grant Pakistan (FFCGP), the event reflects Pakistan’s commitment to tackling AMR as a shared challenge across human, animal, and environmental health sectors.

Thank you to PTV News for spotlighting this important dialogue and amplifying the message that sustainable action against antimicrobial resistance is critical for the health and well-being of communities nationwide.



https://www.facebook.com/share/v/1AuisJrWJJ/

22/01/2026

📍 Advancing Sustainable AMR Surveillance in Pakistan

The Country Roundtable on Sustainability of Antimicrobial Resistance, Use, and Consumption (AMR/U/C) Surveillance was held on 20 January 2026 in Islamabad, convening senior government leaders, technical experts, development partners, and provincial representatives to reflect on progress and shape the way forward.

The roundtable brought together stakeholders from human health, animal health, aquaculture, environment, and regulatory sectors to review surveillance data, share achievements, and discuss how AMR systems can be sustained beyond project cycles. Key discussions focused on translating evidence into policy action, adapting national and provincial strategies, and mobilizing resources to protect the effectiveness of life-saving medicines.

Hosted by the National Institutes of Health (NIH) in collaboration with the Fleming Fund Country Grant Pakistan (FFCGP) and partners, the event reinforced the importance of a One Health approach, strong governance, and multisectoral coordination in addressing AMR as a long-term public health and sustainability challenge.

Through strategic dialogue, panel discussions, and collective reflection, the roundtable reaffirmed Pakistan’s commitment to strengthening AMR surveillance systems that are resilient, integrated, and nationally owned.

🤝 Sustainable solutions today are essential to safeguard public health tomorrow.



DAI Fleming Initiative Mott MacDonald Health Security Partners National Institutes of Health Pakistan (NIH) Ministry of National Health Services, Regulations & Coordination Ministry of Food and Agriculture Health Services Academy, Islamabad FCDO Services

22/01/2026

📍 Strengthening Pakistan’s Fight Against Antimicrobial Resistance (AMR)

The 4th Meeting of the National Multisectoral Antimicrobial Resistance Steering Committee was held on 19 January 2026 in Islamabad, bringing together key stakeholders from human health, animal health, and policy sectors to review progress and chart the way forward on AMR in Pakistan.

The meeting focused on:
🔹 Updates on AMR surveillance and progress in human and animal health sectors
🔹 The development of National Action Plan (NAP 2.0) on AMR
🔹 Strategic objectives and priority interventions to strengthen a coordinated, multisectoral response
🔹 Collective discussion on challenges, opportunities, and next steps

Chaired by senior leadership from the Ministry of National Health Services, Regulations & Coordination (MoNHSR&C) and hosted by the National Institutes of Health (NIH), the meeting reaffirmed Pakistan’s commitment to a One Health approach—recognizing the interconnectedness of human, animal, and environmental health in tackling AMR.

Collaborative platforms like this steering committee are critical to ensuring evidence-based decision-making, cross-sector coordination, and sustainable action against one of the most pressing public health challenges of our time.

🤝 Together, we move closer to safeguarding the effectiveness of life-saving medicines for current and future generations.

05/01/2026

📍 Annual Programme Review Meeting | FFCGP
🗓️ 22–24 December 2025 | Lahore

Over three intensive days, the Fleming Fund Country Grant Pakistan (FFCGP) team, alongside national and provincial partners, came together to review Q8 progress, reflect on Phase 2 delivery (2024–2025), and collectively shape priorities for Q9 and programme close-out.

The discussions spanned human, animal, and environmental health—highlighting achievements in AMR surveillance, laboratory strengthening, clinical engagement, governance, and sustainability planning. From data-driven insights to honest reflections on challenges and lessons learnt, the meeting reinforced the value of coordination, evidence, and shared ownership in tackling antimicrobial resistance.

Grateful to all partners, provincial teams, and colleagues for the collaboration and commitment to building a more resilient AMR surveillance system in Pakistan.

01/01/2026

✨ Happy New Year 2026! ✨
As we step into a new year, the Fleming Fund Country Grant Pakistan team reflects with gratitude on a year of collaboration, progress, and impact in strengthening antimicrobial resistance (AMR) surveillance across Pakistan.
In 2026, we remain committed to working alongside our national and provincial partners to build resilient health systems, strengthen laboratory capacity, and advance evidence-based action against AMR—protecting lives today and for generations to come.
Thank you to our partners, stakeholders, and colleagues for your continued trust and collaboration. We look forward to another year of shared purpose and meaningful impact.

Wishing everyone a year of health, hope, and progress. 🌱

31/12/2025

🌍 Strengthening Pakistan’s Response to Antimicrobial Resistance (AMR) through One Health

DAI Fleming Fund Country Grant Pakistan (FFCGP) proudly participated in the National Policy Dialogue on Antimicrobial Resistance and the One Health Approach, organized by the Health Services Academy (HSA) with our support.

The high-level forum brought together senior government officials, policymakers, development partners, academia, and technical experts to deliberate on emerging AMR challenges and integrated solutions across human, animal, and environmental health sectors.

Our panelists, Dr. Qadeer Ahsan and Dr. Tauqeer Mustafa, highlighted FFCGP’s key interventions in:

✅ Strengthening AMR surveillance

✅ Advancing the One Health approach

✅ Promoting evidence-based policymaking in Pakistan

The dialogue reinforced the importance of multisectoral collaboration and sustainable investments to effectively combat AMR. We are honored that the Honorable Federal Minister for Health Kamal formally recognized our team for our continued technical and programmatic support in strengthening Pakistan’s AMR and One Health response.

30/12/2025

📊 Dissemination Event | Turning Evidence into Action on AMR in Pakistan

Stakeholders convened in Islamabad for the Dissemination Event on Pakistan Antimicrobial Consumption Analysis (2022–2024) and the Burden of Disease of Healthcare-Associated Infections (HAIs)—bringing critical evidence to the forefront of Pakistan’s AMR response.

🔍 Key insights shared

High and often inappropriate antimicrobial use continues to drive resistance across healthcare settings.

Healthcare-associated infections significantly increase patient morbidity, mortality, and healthcare costs.

Gaps in routine surveillance and standardized reporting limit timely, evidence-based decision-making.

📌 Key recommendations highlighted

Strengthen antimicrobial stewardship programmes across public and private healthcare facilities.

Institutionalize routine AMR, AMC, and HAI surveillance to guide policy and clinical practice.

Enhance infection prevention and control (IPC) measures to reduce preventable infections and antimicrobial use.

Promote multisectoral coordination under the One Health approach to ensure sustainable impact.

The discussions reinforced the importance of translating data into policy action to safeguard patient safety and protect the effectiveness of life-saving antimicrobials.

19/12/2025